A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […]